This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Fluticasone Salmeterol MDPI
Teva Pharmaceutical Industries Ltd.
Drug Names(s): Fluticasone/Salmeterol Spiromax Inhalation Powder, Fluticasone/Dalmeterol MDPI, fluticasone/salmeterol multi-dose powder inhaler
Fluticasone and Salmeterol MDPI is a new formulation of this combination using Teva's multi-dose powder inhaler device, with an enhanced lung delivery that is designed to allow lower doses to achieve the same clinical outcomes as Advair Diskus.
BioMedTracker has a separate profile for this combination using the metered dose inhaler, seen under Fluticasone and Salmeterol (MDI).
Fluticasone Salmeterol MDPI News
Pink Sheet Advair, Serevent add "black box"
Additional information available to subscribers only: